Stereotactic Breast Biopsy Made Easy with Mammomat Inspiration

SiemensSiemens Healthcare has introduced its new biopsy unit to the market, enhancing the Mammomat Inspiration digital mammography platform with stereotactic breast biopsy. The digital system with basic functions for screening has been on the market since the end of 2007. Since then, it has been installed in countless hospitals and private practices worldwide. The new device with its supplemental biopsy function recently went into operation in Copenhagen and Dortmund. Using the new system, all workflows are performed faster and easier than ever before.

The biopsy unit is easy to install; it simply slides on the full-field detector of the mammography platform. Using the same detector ensures that the radiographic image quality remains high. The mammography system detects the biopsy unit and automatically switches all hardware and software configuration settings to the biopsy mode. A preconfigured examination workflow and a well-defined user interface intuitively guide clinical personnel through the intervention.

Dr. Ilse Vejborg, Head of Radiology at Rigshospitalet in Copenhagen, is impressed by the system advantages: "Performing stereotactic biopsy on Mammomat Inspiration, we found the system easy to learn and easy to use. Our first impression is that the new system is very efficient to tackle microcalcifications, which are clearly depicted on the stereo images and accurately collected by the biopsy unit."

The system enables vertical or lateral needle access to lesions. Another advantage is that only one space-saving, ergonomic workstation is required for all applications of the mammography platform.

With Mammomat Inspiration, screening, diagnostics, biopsy, and tomosynthesis (in the future) are all based on one digital platform for the first time. A hospital or private practice can purchase a screening device as needed, and enhance this basic system with the biopsy unit and, eventually, with 3D tomosynthesis currently in development.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of €11.17 billion, orders of €11.78 billion, and group profit of €1.23 billion (preliminary figures). Further information can be found by visiting www.siemens.com/healthcare.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...